Early Detection of Alzheimer's & The Promise of New Treatments
RSVP Below *This event will take place at our partner organization: Little House, 800 Middle Avenue, Menlo Park, CA
*This event will take place at our partner organization: Little House, 800 Middle Avenue, Menlo Park, CA
Kensington Senior Living is proud to partner with Dr. Armen Moughamian, Director of the Ray Dolby Brain Health Center for this educational event. Discover how early detection, combined with innovative treatments like Leqembi, is paving the way for a brighter future for individuals and families affected by Alzheimer’s.
Our expert will share the latest diagnostic tools and strategies for early detection; comprehensive care and management approaches; insights into holistic care plans, lifestyle modifications and support strategies to enhance the quality of life for both individuals with Alzheimer’s and their caregivers. Submit your top questions when you register and have them answered live during the Q&A!
What You Will Learn
Basic Science: How Leqembi Fights Amyloid Plaques in the Brain
Efficacy: Progress in First Few Months after FDA-Approval
Impact: What Leqembi Means for Individuals, Families & Caregivers
Accessibility: Medicare Coverage
Whether you are a healthcare professional, a caregiver, someone concerned about their cognitive health, or simply interested in the latest advancements in Alzheimer’s research, this webinar offers valuable insights that can make a difference. Don’t miss out on this unique opportunity to gain knowledge, ask questions, and be part of the conversation shaping the future of Alzheimer’s disease treatment.
Armen Moughamian, MD, PhD, Director of the Ray Dolby Brain Health Center, is a neurologist who cares for people with neurodegenerative brain illnesses including Alzheimer’s disease and other dementias, as well as movement disorders such as Huntington’s disease and spinocerebellar ataxias. Board certified in neurology, Dr. Moughamian studies the development and progression of neurodegenerative diseases, as well as investigational and U.S. Food and Drug Administration-approved treatments for these illnesses. Dr. Moughamian received his medical degree and a Ph.D. in neuroscience from Perelman School of Medicine at the University of Pennsylvania, through the Medical Scientist Training Program.
For questions, email Amber Brooksher, Sales Support Specialist, at email@example.com.
(Thursday) 4:00 pm - 5:30 pm PDT
800 Middle Avenue, Menlo Park, CA 94025
RSVPing is closed at this time.
Can not make it to this event?Change my RSVP